The Safety and Efficacy of Tranexamic Acid in Oncology Patients Undergoing Endoprosthetic Reconstruction and a ROTEM-Based Evaluation of Their Hemostatic Profile: A Pilot Study.

Andreas G TsantesIoannis G TrikoupisDimitrios V PapadopoulosStavros GoumenosDaniele Piovani Georgios K NikolopoulosArgyri GialerakiStefanos BonovasPanayiotis J PapagelopoulosVasilios A KontogeorgakosArgirios E Tsantes

Published in: Cancers (2021)

Tranexamic acid was associated with a significant reduction in perioperative blood loss and transfusion requirements without a complete shutdown of the fibrinolysis. Larger studies are warranted to assess the frequency of these outcomes in musculoskeletal oncology patients.

Keyphrases

patients undergoing
palliative care
end stage renal disease
cardiac surgery
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
acute kidney injury
adipose tissue
patient reported outcomes
patient reported
insulin resistance
case control